E Barbieri Selected Research

E Barbieri Research Topics

Disease

16	Neoplasms (Cancer) 01/2018 - 01/2000
4	Breast Neoplasms (Breast Cancer) 12/2013 - 11/2010
4	Ewing Sarcoma (Sarcoma, Ewing) 05/2011 - 01/2003
3	Neoplasm Metastasis (Metastasis) 11/2012 - 11/2003
3	Sarcoma (Soft Tissue Sarcoma) 11/2012 - 03/2001
2	Coronary Stenosis (Coronary Artery Stenosis) 01/2020 - 04/2001
2	Osteoporosis 01/2020 - 01/2018
2	Neuroblastoma 08/2015 - 01/2015
2	Hemorrhage 09/2011 - 07/2008
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2009 - 02/2004
1	Hypertension (High Blood Pressure) 01/2020
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020
1	Cushing Syndrome 01/2020
1	Pharyngitis (Sore Throat) 08/2019
1	Otitis Media 08/2019
1	Hypoxia (Hypoxemia) 01/2015
1	Pathologic Complete Response 12/2013
1	Prostatic Neoplasms (Prostate Cancer) 09/2011
1	Colitis 09/2011
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 09/2011
1	Hemophilia B (Haemophilia B) 07/2008
1	Hepatocellular Carcinoma (Hepatoma) 07/2008
1	Hemophilia A (Haemophilia) 07/2008
1	Fibrosis (Cirrhosis) 07/2008
1	End Stage Liver Disease 07/2008
1	Respiratory Insufficiency (Respiratory Failure) 09/2007
1	Patent Ductus Arteriosus 06/2004
1	Second Primary Neoplasms (Neoplasms, Second) 01/2004
1	Cardiotoxicity 01/2004
1	Infertility (Sterility) 03/2003
1	Delayed Puberty 03/2003
1	Hypogonadism (Hypergonadotropic Hypogonadism) 03/2003
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2001
1	Infarction (Infarctions) 04/2001
1	Myocardial Infarction 04/2001
1	Hodgkin Disease (Hodgkin's Disease) 07/2000
1	Carcinoma (Carcinomatosis) 01/2000

Drug/Important Bio-Agent (IBA)

2	MineralsIBA 01/2020 - 01/2018
2	SteroidsIBA 01/2020 - 01/2018
2	Ifosfamide FDA LinkGeneric 05/2011 - 03/2001
2	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2011 - 01/2004
1	C-Reactive ProteinIBA 01/2020
1	CeramidesIBA 01/2020
1	LipidsIBA 01/2020
1	Amoxicillin (Wymox)FDA LinkGeneric 08/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2019
1	CollagenIBA 01/2018
1	human ERBB2 proteinIBA 01/2018
1	GlucocorticoidsIBA 01/2018
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 08/2015
1	p38 Mitogen-Activated Protein KinasesIBA 08/2015
1	NSC-87877IBA 08/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015
1	RG7388IBA 01/2015
1	ErbB Receptors (EGF Receptor)IBA 12/2013
1	Interleukin-12 (IL 12)IBA 10/2012
1	VaccinesIBA 10/2012
1	Beclomethasone (Beclometasone)FDA Link 09/2011
1	Dactinomycin (Actinomycin)FDA LinkGeneric 05/2011
1	Etoposide (VP 16)FDA LinkGeneric 05/2011
1	Vincristine (Oncovin)FDA LinkGeneric 05/2011
1	Trastuzumab (Herceptin)FDA Link 11/2010
1	Imatinib Mesylate (Gleevec)FDA Link 02/2009
1	Transcription Factors (Transcription Factor)IBA 02/2009
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 07/2008
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 02/2004
1	Testosterone (Sustanon)FDA Link 03/2003
1	Alkylating AgentsIBA 03/2003
1	Estradiol (Delestrogen)FDA LinkGeneric 03/2003
1	DNA (Deoxyribonucleic Acid)IBA 08/2001
1	Coloring Agents (Dyes)IBA 04/2001
1	Epirubicin (Ellence)FDA LinkGeneric 03/2001
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 03/2001
1	Mesna (Coenzyme M)FDA LinkGeneric 03/2001

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 08/2013 - 07/2000
8	Radiotherapy 09/2011 - 01/2000
4	Neoadjuvant Therapy 12/2013 - 11/2003
3	Therapeutics 01/2020 - 11/2003
2	Adjuvant Chemotherapy 04/2004 - 03/2001
1	Synchrotrons 01/2020
1	Segmental Mastectomy (Lumpectomy) 12/2013
1	Mammaplasty (Breast Reconstruction) 02/2012
1	Induction Chemotherapy 05/2011
1	Surgical Hemostasis 07/2008
1	Operative Surgical Procedures 07/2008
1	Perioperative Period 07/2008
1	Liver Transplantation 07/2008
1	Mastectomy (Mammectomy) 09/2007
1	Catheters 06/2004
1	Pituitary Irradiation 03/2003
1	Aftercare (After-Treatment) 03/2003
1	MACOP-B regimen 09/2001